|
注册号: Registration number: |
ChiCTR2000035094 |
|
最近更新日期: Date of Last Refreshed on: |
2020-07-31 17:33:53 |
|
注册时间: Date of Registration: |
2020-07-31 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
结节性硬化多中心注册研究 |
|
Public title: |
Tuberous Sclerosis Complex MultiCenter Register |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
结节性硬化多中心注册研究 |
|
Scientific title: |
Tuberous Sclerosis Complex MultiCenter Register |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
陈亚楠 |
研究负责人: |
韩雄 |
|
Applicant: |
Chen Yanan |
Study leader: |
Han Xiong |
|
申请注册联系人电话: Applicant telephone: |
+86 15838310801 |
研究负责人电话:
Study leader's |
+86 13837171615 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
chenyanan7722@163.com |
研究负责人电子邮件: Study leader's E-mail: |
hanxiong7589@126.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
河南省郑州市金水区纬五路七号 |
研究负责人通讯地址: |
河南省郑州市金水区纬五路七号 |
|
Applicant address: |
7 Weiwu Road, Jinshui District, Zhengzhou, Henan |
Study leader's address: |
7 Weiwu Road, Jinshui District, Zhengzhou, Henan |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
河南省人民医院 |
||
|
Applicant's institution: |
Henan Provincial People's Hospital |
||
|
研究负责人所在单位: |
河南省人民医院 |
||
|
Affiliation of the Leader: |
Henan Provincial People's Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
(2020)伦理第(95)号) |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
河南省人民医院医学伦理委员会 |
||
|
Name of the ethic committee: |
The Ethics Committee of Henan Provincial People's Hospital |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2020-06-01 00:00:00 | ||
|
伦理委员会联系人: |
李立 |
||
|
Contact Name of the ethic committee: |
LI Li |
||
|
伦理委员会联系地址: |
河南省郑州市金水区纬五路七号 |
||
|
Contact Address of the ethic committee: |
7 Weiwu Road, Jinshui District, Zhengzhou, Henan |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 0371-87160680 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
河南省人民医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Henan Provincial People's Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
河南省郑州市金水区纬五路七号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
7 Weiwu Road, Jinshui District, Zhengzhou, Henan |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
N/A |
||||||||||||||||||||||
|
Source(s) of funding: |
N/A |
||||||||||||||||||||||
|
研究疾病: |
结节性硬化症 |
||||||||||||||||||||||
|
Target disease: |
tuberous sclerosis complex |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
观察性研究 |
||||||||||||||||||||||
|
Study type: |
Observational study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
1.探讨TSC患者脑影像学分型特征与基因分型关系及其演变规律、癫痫发作的分型特征与演变规律及对治疗的反应、面部结节的分型特征与基因分型关系及其演变规律、TSC相关神经精神障碍/TAND-L的发病特征与演变规律、TSC患者眼心肺肾相关表现的演变规律; 2.评估和调查TSC患者的生活质量、调查TSC相关检查和治疗措施的应用现状和治疗缺口。 |
||||||||||||||||||||||
|
Objectives of Study: |
1.To investigate the relationship between the features of brain imaging classification and gene classification and their evolution, the features of epilepsy classification and evolution, the response to treatment, the features of facial nodules classification and gene classification, the features and evolution of TSC / TAND-L, the features and evolution of eye, heart, lung and kidney related manifestations in patients with TSC; 2.To evaluate and investigate the quality of life of patients with TSC, the current status and treatment gaps of TSC related examination and treatment. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
(1)患有严重消化、心血管、呼吸、肝脏、泌尿疾病者; |
||||||||||||||||||||||
|
Exclusion criteria: |
(1) Patients with severe digestive, cardiovascular, respiratory, liver, Urinary Diseases; |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2020-08-01 00:00:00至 To 2028-05-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2020-08-01 00:00:00 至 To 2028-05-31 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
正在进行 Recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
未使用 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Not used |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
N/A |
|
Blinding: |
N/A |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
是Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
原始数据将以文章发表的方式共享 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
Raw data will be shared in the form of articles published |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
病例记录表 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |